United States · Pharmaceuticals startup

Xanodyne Pharmaceuticals

Xanodyne Pharmaceuticals was an integrated specialty pharmaceutical company focused on women’s healthcare and pain management.

Funding reportedLast round: Undisclosed round

PharmaceuticalsNewport, United States

About Xanodyne Pharmaceuticals

Xanodyne Pharmaceuticals was an integrated specialty pharmaceutical company focused on women’s healthcare and pain management.

Founded around 2000-2001 and based in the Newport, Kentucky area, it served patients and physicians across the United States. The company developed, marketed, and distributed prescription medicines, showcasing both development and commercial capabilities. Xanodyne's product offerings included prescription pain management pharmaceuticals and a line of prenatal vitamins. Notable products included Lysteda for treating cyclic heavy menstrual bleeding, Zipsor for mild to moderate acute pain, and XP12B and XP20B for heavy menstrual bleeding and mild to moderate pain, respectively. The company also had products like Duraclon and Methadone Hydrochloride Injection, which were associated with pain management.

What company datasets say Xanodyne Pharmaceuticals raised

Funding, as reported

Reported in all$308Min dollars
Rounds5
Last roundUndisclosed round
Last round size$88M
Last round dateOct 2009
Investors listed11
SEC Form D$126M sold, 3 filings, last Oct 2009

Founders and team

From the SEC filings it signed: 8 on the team.

  • Daniel W. DochertyExecutive Officeri
  • Gary A. ShangoldExecutive Officeri
  • Kevin T. AndersonExecutive Officeri
  • Michael M. ValentinoExecutive Officer, Directori
  • Natasha W. GiordanoExecutive Officeri
  • Peter W. WentworthExecutive Officeri
  • Rita M. O'ConnorExecutive Officeri
  • Thomas P. JenningsExecutive Officeri

On the board, as filediCraig A. ToomanDennis PurcellJames A. ShannonPatrick M. EnrightRolf A. ClassonSteven St. PeterVaughn M. Kailian

The company, in detail

What they build

Known for

medicalbiotechnologyservicespharmaceuticalsb2bpain management womens healthpharmaceutical manufacturinglife sciences

Built with from their website

Google Tag ManagerViewport MetaWebSite X5Microsoft ExchangeMicrosoft 365 Apps & ServicesMobile FriendlyOpen GraphjQueryGoogle AnalyticsGoDaddy Domains

+6 more

Microsoft Exchange OnlineRemoteMicrosoft 365OutlookMicrosoft Email ProvidersGoDaddy Hosting

Sector
Pharmaceuticals
Industry code
NAICS 325412, SIC 2834
Region
Kentucky
Revenue
$38M a year, as listed
Full record
Every detail in the company directory

Pharmaceuticals in United States

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Xanodyne Pharmaceuticals in front of investors. Or tell us what we have wrong.